MedicaMetrix, Inc. is a Delaware company that produces urological medical devices with demonstrated “comparative effectiveness”, i.e., that reduce the cost of healthcare, while improving clinical outcomes.

MedicaMetrix's first product, ProstaGlove™, enables the quantitative measurement of prostate size that will become the new "gold standard" for prostate exams and prostate cancer diagnosis.

ProstaGlove is Not available for Sale in the United States.
Investigational device limited by Federal law to investigational use only.

Site last updated: 12/4/2011